Elotuzumab and dexamethasone for relapsed or refractory multiple myeloma patients: A retrospective study.

Zachary Gross; Ashkon Rahbari; Eric Wirtschafter; Tanya M. Spektor; Kyle A. Udd; Sean Bujarski; Michael Ghermezi; Jason D. Nosrati; Aleksandra Vidisheva; Benjamin Eades; Gary Cecchi; Tina Maluso; Regina Swift; James R. Berenson

doi:10.1111/EJH.13058

Elotuzumab and dexamethasone for relapsed or refractory multiple myeloma patients: A retrospective study.

Zachary Gross
, Ashkon Rahbari
, Eric Wirtschafter
, Tanya M. Spektor
, Kyle A. Udd
, Sean Bujarski
, Michael Ghermezi
, Jason D. Nosrati
, Aleksandra Vidisheva
, Benjamin Eades
, Gary Cecchi
, Tina Maluso
, Regina Swift
, James R. Berenson

Institute for Myeloma and Bone Cancer Research, West Hollywood, CA, USA.
Institute for Myeloma and Bone Cancer Research West Hollywood CA USA
UCLA Medical Center
Oncotherapeutics, West Hollywood, CA, USA.
Michigan State University
University of Arizona
James R Berenson, MD Inc, West Hollywood, CA, USA.
Northern California Hematology, Berkeley, CA, USA.

Research output: Contribution to journal › Article › peer-review

Original language	American English
Journal	European Journal of Haematology
Volume	100
Issue number	6
DOIs	https://doi.org/10.1111/EJH.13058
State	Published - Jun 1 2018
Externally published	Yes

Disciplines

Medicine and Health Sciences
Oncology
Internal Medicine

Access to Document

10.1111/EJH.13058License: Unspecified

Cite this

Gross, Z., Rahbari, A., Wirtschafter, E., Spektor, T. M., Udd, K. A., Bujarski, S., Ghermezi, M., Nosrati, J. D., Vidisheva, A., Eades, B., Cecchi, G., Maluso, T., Swift, R., & Berenson, J. R. (2018). Elotuzumab and dexamethasone for relapsed or refractory multiple myeloma patients: A retrospective study. European Journal of Haematology, 100(6). https://doi.org/10.1111/EJH.13058

@article{8e93835f69074d5ba1da80446056352c,

title = "Elotuzumab and dexamethasone for relapsed or refractory multiple myeloma patients: A retrospective study.",

author = "Zachary Gross and Ashkon Rahbari and Eric Wirtschafter and Spektor, \{Tanya M.\} and Udd, \{Kyle A.\} and Sean Bujarski and Michael Ghermezi and Nosrati, \{Jason D.\} and Aleksandra Vidisheva and Benjamin Eades and Gary Cecchi and Tina Maluso and Regina Swift and Berenson, \{James R.\}",

year = "2018",

month = jun,

day = "1",

doi = "10.1111/EJH.13058",

language = "American English",

volume = "100",

journal = "European Journal of Haematology",

number = "6",

}

TY - JOUR

T1 - Elotuzumab and dexamethasone for relapsed or refractory multiple myeloma patients: A retrospective study.

AU - Gross, Zachary

AU - Rahbari, Ashkon

AU - Wirtschafter, Eric

AU - Spektor, Tanya M.

AU - Udd, Kyle A.

AU - Bujarski, Sean

AU - Ghermezi, Michael

AU - Nosrati, Jason D.

AU - Vidisheva, Aleksandra

AU - Eades, Benjamin

AU - Cecchi, Gary

AU - Maluso, Tina

AU - Swift, Regina

AU - Berenson, James R.

PY - 2018/6/1

Y1 - 2018/6/1

UR - https://onlinelibrary.wiley.com/doi/full/10.1111/ejh.13058

U2 - 10.1111/EJH.13058

DO - 10.1111/EJH.13058

M3 - Article

VL - 100

JO - European Journal of Haematology

JF - European Journal of Haematology

IS - 6

ER -

Elotuzumab and dexamethasone for relapsed or refractory multiple myeloma patients: A retrospective study.

Disciplines

Access to Document

Other files and links

Cite this